Date Filed | Type | Description |
05/16/2023 |
4
| HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 152 options to buy
@ $0 |
|
05/16/2023 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 485 options to buy
@ $0 |
|
05/16/2023 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 1,818 options to buy
@ $0 |
|
03/09/2023 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 61 options to buy
@ $0 |
|
03/09/2023 |
4
| HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 545 options to buy
@ $0 |
|
03/09/2023 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 545 options to buy
@ $0 |
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Grove Janet P (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Granted 840 options to buy
@ $1.78, valued at
$1.5k
|
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/29/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/18/2022 |
4/A
| Johnson Shane Aaron (Sr VP & General Manager) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Disposed/sold 4,200 options to buy
@ $2.78, valued at
$11.7k
|
|
11/18/2022 |
4/A
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Disposed/sold 4,200 options to buy
@ $2.78, valued at
$11.7k
|
|
11/18/2022 |
4/A
| HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Disposed/sold 4,200 options to buy
@ $2.78, valued at
$11.7k
|
|
11/18/2022 |
4/A
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Disposed/sold 15,000 options to buy
@ $2.78, valued at
$41.7k
|
|
11/18/2022 |
4/A
| WOUDENBERG MICHAEL (COO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Disposed/sold 7,500 options to buy
@ $2.78, valued at
$20.9k
|
|
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/02/2022 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 1,515 options to buy
@ $0 |
|
06/02/2022 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Unknown transaction of 13,636 options to buy
@ $0 |
|
05/19/2022 |
4
| Baldasare Bryan T (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.
Txns:
| Granted 14,000 options to buy
@ $0.8, valued at
$11.2k
|
|
|